Blast phase myeloproliferative neoplasm: contemporary review and 2024 treatment algorithm

A Tefferi, H Alkhateeb, N Gangat - Blood cancer journal, 2023 - nature.com
Leukemic transformation in myeloproliferative neoplasms (MPN), also referred to as “blast-
phase MPN”, is the most feared disease complication, with incidence estimates of 1–4% for …

Emerging DNA Methylome Targets in FLT3-ITD-Positive Acute Myeloid Leukemia: Combination Therapy with Clinically Approved FLT3 Inhibitors

M Tecik, A Adan - Current Treatment Options in Oncology, 2024 - Springer
Current Treatment Options in Oncology and how they modulate FLT3I's activity is important
to rationalize combinational treatment approaches including FLT3Is and modulators of …

IDH1/2 inhibitor monotherapy in blast‐phase myeloproliferative neoplasms: A multicentre experience.

N Gangat, H Ajufo, M Abdelmagid… - British journal of …, 2023 - search.ebscohost.com
A total of 14 consecutive I IDH1/2 i-mutated patients with MPN-BP (median age 76 years)
received ivosidenib (I ni= 5) or enasidenib (I ni= 9), either in the up-front (I ni= 8) or relapsed …

Induction of AML cell differentiation using HOXA9/DNA binding inhibitors as a potential therapeutic option for HOXA9‐dependent AML

M Lambert, S Jambon, MA Bouhlel, S Depauw… - …, 2024 - Wiley Online Library
The mainstay of acute myeloid leukemia (AML) treatment still relies on traditional
chemotherapy, with a survival rate of approximately 30% for patients under 65 years of age …

MT1E in AML: a gateway to understanding regulatory cell death and immunotherapeutic responses

X Zhuang, P Chen, K Yang, R Yang… - Journal of Leukocyte …, 2024 - academic.oup.com
Regulated cell death (RCD) plays a crucial role in the initiation and progression of tumors,
particularly in acute myeloid leukemia (AML). This study investigates the prognostic …

Epigenetics in myeloproliferative neoplasms

G Greenfield, MF McMullin - Frontiers in Oncology, 2023 - frontiersin.org
The myeloproliferative neoplasms (MPNs) are a group of acquired clonal disorders where
mutations drive proliferative disease resulting in increased blood counts and in some cases …

Targeted single‐cell RNA sequencing analysis reveals metabolic reprogramming and the ferroptosis‐resistant state in hematologic malignancies

X Shen, P Dong, J Kong, N Sun, F Wang… - Cell Biochemistry …, 2023 - Wiley Online Library
Hematologic malignancies are the most common hematopoietic diseases and a major
public health concern. However, the mechanisms underlying myeloid tumors remain …

Cancer Biomarkers and Precision Oncology: A Review of Recent Trends and Innovations

M AlDoughaim, N AlSuhebany… - Clinical Medicine …, 2024 - journals.sagepub.com
The discovery of cancer-specific biomarkers has resulted in major advancements in the field
of cancer diagnostics and therapeutics, therefore significantly lowering cancer-related …

[PDF][PDF] Impact of IDH Mutations on DNA Methylation of Acute Myeloid Leukemia Related Genes: A Review Article

DM Bayram, FM Lafta, BF Matti - Journal of the Faculty of Medicine Baghdad, 2024 - iasj.net
Acute myeloid leukemia is one of the deadliest hematologic malignancies that is marked by
genetic alterations, abnormal cellular functions and proliferation. Mutations in isocitrate …

[PDF][PDF] FACULTÉ DE MÉDECINE HENRI WAREMBOURG

A SARRAZIN - 2020 - pepite-depot.univ-lille.fr
RESUME L'inceste et sa prohibition apparaissent comme des notions complexes qui ne
supportent de définition qu'à travers les différents champs qui l'ont étudié. L'inceste …